Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-Social Distancing Measures.

influenza influenza viruses nonhealthcare settings nonpharmaceutical measures pandemic pandemic influenza public health respiratory infections social distancing measures viruses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 7 2 2020
medline: 22 6 2021
entrez: 7 2 2020
Statut: ppublish

Résumé

Influenza virus infections are believed to spread mostly by close contact in the community. Social distancing measures are essential components of the public health response to influenza pandemics. The objective of these mitigation measures is to reduce transmission, thereby delaying the epidemic peak, reducing the size of the epidemic peak, and spreading cases over a longer time to relieve pressure on the healthcare system. We conducted systematic reviews of the evidence base for effectiveness of multiple mitigation measures: isolating ill persons, contact tracing, quarantining exposed persons, school closures, workplace measures/closures, and avoiding crowding. Evidence supporting the effectiveness of these measures was obtained largely from observational studies and simulation studies. Voluntary isolation at home might be a more feasible social distancing measure, and pandemic plans should consider how to facilitate this measure. More drastic social distancing measures might be reserved for severe pandemics.

Identifiants

pubmed: 32027585
doi: 10.3201/eid2605.190995
pmc: PMC7181908
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

976-984

Références

J Int Med Res. 2020 Jan;48(1):300060518764268
pubmed: 29569977
Epidemiology. 2015 Nov;26(6):862-72
pubmed: 26133025
BMJ Open. 2013 Feb 26;3(2):
pubmed: 23447463
Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3146-3154
pubmed: 30647115
PLoS One. 2017 Feb 2;12(2):e0170698
pubmed: 28151940
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6146-51
pubmed: 15071187
BMC Infect Dis. 2018 Jan 10;18(1):29
pubmed: 29321005
Emerg Infect Dis. 2006 Jan;12(1):81-7
pubmed: 16494722
Nihon Koshu Eisei Zasshi. 2013 Apr;60(4):204-11
pubmed: 23909187
Am J Public Health. 2007 Apr;97 Suppl 1:S49-56
pubmed: 17413059
PLoS One. 2017 May 19;12(5):e0177672
pubmed: 28542360
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2825-30
pubmed: 21282645
Epidemics. 2019 Sep;28:100348
pubmed: 31235334
Vaccine. 2018 Nov 19;36(48):7316-7323
pubmed: 30361122
Emerg Infect Dis. 2010 Mar;16(3):538-41
pubmed: 20202441
J Occup Environ Med. 2017 Sep;59(9):822-829
pubmed: 28692009
N Engl J Med. 2010 Jun 10;362(23):2175-2184
pubmed: 20558368
BMJ Open. 2017 Mar 6;7(3):e013159
pubmed: 28264827
Emerg Infect Dis. 2011 Sep;17(9):1599-607
pubmed: 21888784
J Hosp Infect. 2008 Nov;70(3):272-7
pubmed: 18799243
Int J Infect Dis. 2017 Jul;60:77-82
pubmed: 28483722
Epidemiology. 2010 Nov;21(6):842-6
pubmed: 20805752
PLoS Med. 2006 Sep;3(9):e361
pubmed: 16881729
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18238-43
pubmed: 22042838
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):4023-4028
pubmed: 28351976
Commun Dis Intell Q Rep. 2011 Mar;35(1):10-5
pubmed: 21698978
PLoS One. 2015 Dec 15;10(12):e0144839
pubmed: 26669757
Int J Environ Res Public Health. 2013 Sep 30;10(10):4690-700
pubmed: 24084677
Lancet Infect Dis. 2009 Aug;9(8):473-81
pubmed: 19628172
Emerg Infect Dis. 2014 Jul;20(7):1203-7
pubmed: 24963800
MMWR Recomm Rep. 2017 Apr 21;66(1):1-34
pubmed: 28426646
J R Soc Interface. 2015 Feb 6;12(103):
pubmed: 25540241
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7588-93
pubmed: 17416677
JAMA. 2007 Aug 8;298(6):644-54
pubmed: 17684187
J R Soc Interface. 2008 Jun 6;5(23):631-9
pubmed: 17916550
PLoS One. 2009 Dec 21;4(12):e8356
pubmed: 20027293
Nature. 2006 Jul 27;442(7101):448-52
pubmed: 16642006
Emerg Infect Dis. 2008 Mar;14(3):468-70
pubmed: 18325264
J Occup Health. 2011;53(4):287-92
pubmed: 21597235
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7582-7
pubmed: 17416679
Influenza Other Respir Viruses. 2014 May;8(3):353-9
pubmed: 24506160
Public Health Rep. 2009 Mar-Apr;124(2):193-6
pubmed: 19320359
Emerg Infect Dis. 2020 Jan;26(1):
pubmed: 31855145
Aviat Space Environ Med. 2011 Aug;82(8):782-9
pubmed: 21853856
BMC Public Health. 2018 Apr 18;18(1):518
pubmed: 29669545
Lancet Infect Dis. 2009 May;9(5):291-300
pubmed: 19393959

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH